Tecnimede Group
Emanuel Ramos Franco is an experienced Transport and Logistics Manager currently employed at Tecnimede Group since September 2022. Previously, Emanuel held the position of Responsável e Controlador de Tráfego at Internal Transportes, Lda. from January 2014 to September 2022, where responsibilities included fleet management, transportation coordination, urgent transport control, customer contact, billing, profitability oversight, and contract negotiation. Prior to this, Emanuel provided administrative support at Ramos e Bento Transportes Lda from 2009 to 2010, focusing on billing, supply, and cost control. Academic credentials include a degree in Distribution and Logistics Management from the Polytechnic Institute of Setúbal, along with logistics studies at Universidade do Vale do Itajaí and Karel de Grote-Hogeschool.
Tecnimede Group
1 followers
TECNIMEDE GROUP is composed by pharmaceutical companies of private and 100% Portuguese capital. Started its activity in 1980 and covers the entire life cycle of the medicinal products for human use: development, manufacture, promotion and marketing. TECNIMEDE GROUP's strategy is based on a strong investment in Research, Development and Production of Medicinal Products. It is intended that the results obtained allow to consolidate the Group's position in the Portuguese market and to strengthen exports and internationalization. Atlantic Pharma Brasil and Atlas Pharm (Morocco) are an example of the Group's expansion and development of manufacturing plants. The TECNIMEDE GROUP’s commercial activity is based on: - The solid positioning of the three commercial lines in Portugal; - The direct presence in Spain, Italy, Morocco, Colombia and Brazil; - The establishment of local partnerships in the more than 40 countries where it exports — almost all the European Union countries, as well as several countries in Africa, South America, North America, Asia and the Middle East. TECNIMEDE GROUP's portfolio includes more than 100 products, as a result of its R&D center, which results in more than 2,500 MAs worldwide. Our Mission is the "Improvement and preservation of human life and health through the development, production and marketing of pharmaceutical products with a strong focus on quality and technological innovation.